5 Clonality markers in polycythaemia and primary thrombocythaemia

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Baillière's clinical haematology

• Publication date

  1998-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0950-3536(98)80039-5
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Clonality analysis of hematopoiesis and thrombopoietin levels in patients with essential thrombocythemia.

  1998cited by this paper
• An activating splice donor mutation in the thrombopoietin gene causes hereditary thrombocythaemia

  1998cited by this paper
• X-chromosome inactivation in healthy females: incidence of excessive lyonization with age and comparison of assays involving DNA methylation and transcript polymorphisms.

  1998cited by this paper
• Alfa-interferon in the treatment of essential thrombocythemia: clinical results and evaluation of its biological effects on the hematopoietic neoplastic clone

  1998cited by this paper
• Clonal haemopoiesis in normal elderly women: implications for the myeloproliferative disorders and myelodysplastic syndromes

  1997cited by this paper
• Proposal for Revised Diagnostic Criteria of Essential Thrombocythemia and Polycythemia Vera by the Thrombocythemia Vera Study Group

  1997cited by this paper
• Clonality analysis of hematopoiesis in essential thrombocythemia: advantages of studying T lymphocytes and platelets.

  1997cited by this paper
• Polyclonal haemopoiesis is frequent in patients diagnosed with essential thrombocythaemia.

  1997cited by this paper
• Experience of the Polycythemia Vera Study Group with essential thrombocythemia: a final report on diagnostic criteria, survival, and leukemic transition by treatment.

  1997cited by this paper
• Acquired skewing of X‐chromosome inactivation patterns in myeloid cells of the elderly suggests stochastic clonal loss with age

  1997cited by this paper
• Nonrandom X-inactivation patterns in normal females: lyonization ratios vary with age.

  1996cited by this paper
• Diagnostic and differential criteria of essential thrombocythemia and reactive thrombocytosis.

  1996cited by this paper
• Interstitial deletion constitutes the major mechanism for loss of heterozygosity on chromosome 20q in polycythemia vera.

  1996cited by this paper
• Heritability of X chromosome--inactivation phenotype in a large family.

  1996cited by this paper
• The diagnostic criteria of polycythaemia rubra vera.

  1996cited by this paper
• Clonal analysis of haemopoietic cells in essential thrombocythaemia

  1995cited by this paper
• Behavior of hematopoietic stem cells in a large animal.

  1995cited by this paper
• Clonality and X-inactivation patterns in hematopoietic cell populations detected by the highly informative M27 beta DNA probe.

  1994cited by this paper
• Tissue specificity of X-chromosome inactivation patterns.

  1994cited by this paper
• Clonality in chronic myeloproliferative disorders defined by X‐chromosome linked probes: demonstration of heterogeneity in lineage involvement

  1994cited by this paper
• Transcriptional analysis of the active X-chromosome in normal and clonal hematopoiesis.

  1993cited by this paper
• A novel clonality assay based on transcriptional analysis of the active X chromosome

  1993cited by this paper
• Clonal evolution in acute myeloid leukemia [editorial; comment]

  1993cited by this paper
• X-chromosome inactivation occurs at different times in different tissues of the post-implantation mouse embryo

  1993cited by this paper
• Variable expression of features of normal and neoplastic stem cells in patients with thrombocytosis

  1992cited by this paper
• Methylation of HpaII and HhaI sites near the polymorphic CAG repeat in the human androgen-receptor gene correlates with X chromosome inactivation.

  1992cited by this paper
• Clonality in myeloproliferative disorders.

  1992cited by this paper
• Clonality in myeloproliferative disorders: analysis by means of the polymerase chain reaction.

  1991cited by this paper
• Essential thrombocythemia in two sisters originating from different stem cell levels.

  1990cited by this paper
• Clonal analysis of chronic myeloproliferative disorders using X-linked DNA polymorphisms.

  1990cited by this paper
• The application of X‐chromosome gene probes to the diagnosis of myeloproliferative disease

  1989cited by this paper
• Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

  1987cited by this paper
• Essential thrombocythemia: an interim report from the Polycythemia Vera Study Group.

  1986cited by this paper
• Evidence for the involvement of B lymphoid cells in polycythemia vera and essential thrombocythemia.

  1985cited by this paper
• Use of restriction fragment length polymorphisms to determine the clonal origin of human tumors.

  1985cited by this paper
• Autosomal dominant polycythemia.

  1985cited by this paper
• Primary thrombocythemia: clonal origin of platelets, erythrocytes, and granulocytes in a GdB/GdMediterranean subject.

  1982cited by this paper
• Evidence that essential thrombocythemia is a clonal disorder with origin in a multipotent stem cell

  1981cited by this paper
• Imbalance in X-chromosome expression: evidence for a human X-linked gene affecting growth of hemopoietic cells.

  1979cited by this paper
• Polycythemia vera: stem-cell and probable clonal origin of the disease.

  1976cited by this paper
• Primordial cell pool size and lineage relationships of five human cell types*

  1973cited by this paper
• Gene Action in the X-chromosome of the Mouse (Mus musculus L.)

  1961cited by this paper

• Clonal hematopoiesis in hematological disorders.

  2020cites this paper
• Thrombocytosis

  2019cites this paper
• Hematopoietic stem cells, progenitor cells and leukemic stem cells in adult myeloproliferative neoplasms

  2013cites this paper
• polyclonal hematopoiesis in the majority patients in cytogenetic remission to imatinib but restoration of cells in some CML - Emergence of clonal cytogenetic abnormalities in Ph

  2012cites this paper
• Myeloproliferative Disorders and Myelodysplastic Syndromes

  2007cites this paper
• Classification and molecular biology of polycythemias (erythrocytoses) and thrombocytosis.

  2003cites this paper
• Emergence of clonal cytogenetic abnormalities in Ph- cells in some CML patients in cytogenetic remission to imatinib but restoration of polyclonal hematopoiesis in the majority.

  2003cites this paper
• Cytogenetic and Molecular Genetic Aspects of Essential Thrombocythemia

  2002cites this paper
• Myelofibrosis with myeloid metaplasia following essential thrombocythaemia: actuarial probability, presenting characteristics and evolution in a series of 195 patients

  2002cites this paper
• Idiopathic erythrocytosis – a declining entity

  2001cites this paper
• Current opinion in essential thrombocythemia: pathogenesis, diagnosis, and management.

  2001cites this paper
• The incidences of trisomy 8, trisomy 9 and D20S108 deletion in polycythaemia vera: an analysis of blood granulocytes using interphase fluorescence in situ hybridization

  2000cites this paper